Phase
Condition
Williams Syndrome
Dyskinesias
Manic Disorders
Treatment
N/AClinical Study ID
Ages 18-79 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of primary RLS according to RLS Diagnostic Clinical Interview andInternational Restless Legs Syndrome Study Group Diagnostic Criteria.
Disturbed sleep, with both evening (between 5:00 pm and 8:00 pm) and night time (between 8:00 pm and 8:00 am) symptoms requiring treatment.
Exclusion
Exclusion criteria:
Signs of secondary RLS.
Primary sleep disorder or movement disorder other than RLS.
Unstable medical conditions.
Inability to tolerate dopamine agonists or dopamine antagonists.
Unwilling to discontinue any medications currently being taken to treat RLS symptoms.
Study Design
Connect with a study center
GSK Investigational Site
Camperdown, New South Wales 2050
AustraliaSite Not Available
GSK Investigational Site
Auchenflower, Queensland 4066
AustraliaSite Not Available
GSK Investigational Site
Kippa Ring, Queensland 4021
AustraliaSite Not Available
GSK Investigational Site
Innsbruck, A-6020
AustriaSite Not Available
GSK Investigational Site
Vienna, A-1090
AustriaSite Not Available
GSK Investigational Site
Brussels, 1190
BelgiumSite Not Available
GSK Investigational Site
Charleroi, 6000
BelgiumSite Not Available
GSK Investigational Site
Edegem, 2650
BelgiumSite Not Available
GSK Investigational Site
Liege, 4000
BelgiumSite Not Available
GSK Investigational Site
Liège, 4000
BelgiumSite Not Available
GSK Investigational Site
Liège, 4000
BelgiumSite Not Available
GSK Investigational Site
Glostrup, 2600
DenmarkSite Not Available
GSK Investigational Site
Hvidovre, 2650
DenmarkSite Not Available
GSK Investigational Site
Koebenhavn NV, 2300
DenmarkSite Not Available
GSK Investigational Site
Odense C, DK-5000
DenmarkSite Not Available
GSK Investigational Site
Anzin, 59410
FranceSite Not Available
GSK Investigational Site
Bordeaux, 33000
FranceSite Not Available
GSK Investigational Site
Bron Cedex, 69677
FranceSite Not Available
GSK Investigational Site
Créteil, 94010
FranceSite Not Available
GSK Investigational Site
Créteil, 94010
FranceSite Not Available
GSK Investigational Site
Grenoble Cedex 09, 38043
FranceSite Not Available
GSK Investigational Site
Lille, 59037
FranceSite Not Available
GSK Investigational Site
Montbrison, 42600
FranceSite Not Available
GSK Investigational Site
Nancy Cedex, 54035
FranceSite Not Available
GSK Investigational Site
Pessac Cedex, 33604
FranceSite Not Available
GSK Investigational Site
Muenchen, Bayern 80331
GermanySite Not Available
GSK Investigational Site
Schwerin, Mecklenburg-Vorpommern 19053
GermanySite Not Available
GSK Investigational Site
Chemnitz, Sachsen 09111
GermanySite Not Available
GSK Investigational Site
Koethen, Sachsen-Anhalt 06366
GermanySite Not Available
GSK Investigational Site
Gera, Thueringen 07551
GermanySite Not Available
GSK Investigational Site
Berlin, 12163
GermanySite Not Available
GSK Investigational Site
Bologna, Emilia-Romagna 40123
ItalySite Not Available
GSK Investigational Site
Roma, Lazio 00168
ItalySite Not Available
GSK Investigational Site
Milano, Lombardia 20127
ItalySite Not Available
GSK Investigational Site
Pavia, Lombardia 27100
ItalySite Not Available
GSK Investigational Site
Pisa, Toscana 56126
ItalySite Not Available
GSK Investigational Site
Amsterdam, 1066 EC
NetherlandsSite Not Available
GSK Investigational Site
Geldermalsen, 4191 AH
NetherlandsSite Not Available
GSK Investigational Site
Grubbenvorst, 5971 BB
NetherlandsSite Not Available
GSK Investigational Site
Hoogwoud, 1718 BG
NetherlandsSite Not Available
GSK Investigational Site
Nieuwegein, 3435 CM
NetherlandsSite Not Available
GSK Investigational Site
Roelofarendsveen, 2371 RB
NetherlandsSite Not Available
GSK Investigational Site
Zwolle, 8025 BV
NetherlandsSite Not Available
GSK Investigational Site
Bergen, 5094
NorwaySite Not Available
GSK Investigational Site
Oslo, 0277
NorwaySite Not Available
GSK Investigational Site
Sandvika, N-1338
NorwaySite Not Available
GSK Investigational Site
Barcelona, 08025
SpainSite Not Available
GSK Investigational Site
Granada, 18013
SpainSite Not Available
GSK Investigational Site
Madrid, 28036
SpainSite Not Available
GSK Investigational Site
Palma de Mallorca, 07014
SpainSite Not Available
GSK Investigational Site
San Sebastián, 20014
SpainSite Not Available
GSK Investigational Site
San Sebastián, 20014
SpainSite Not Available
GSK Investigational Site
Zaragoza, 50009
SpainSite Not Available
GSK Investigational Site
Göteborg, SE-413 45
SwedenSite Not Available
GSK Investigational Site
Göteborg, SE-412 55
SwedenSite Not Available
GSK Investigational Site
Helsingborg, SE-252 21
SwedenSite Not Available
GSK Investigational Site
Örebro, 701 85
SwedenSite Not Available
GSK Investigational Site
Örebro, 701 85
SwedenSite Not Available
GSK Investigational Site
Chesterfield, Derbyshire S40 4TF
United KingdomSite Not Available
GSK Investigational Site
Blackpool, Lancashire FY4 3AD
United KingdomSite Not Available
GSK Investigational Site
Frome, Somerset BA11 1EZ
United KingdomSite Not Available
GSK Investigational Site
Coventry, Warwickshire CV6 4DD
United KingdomSite Not Available
GSK Investigational Site
Trowbridge, Wiltshire BA14 9AR
United KingdomSite Not Available
GSK Investigational Site
Corsham, SN13 8NA
United KingdomSite Not Available
GSK Investigational Site
Doncaster, DN1 2EG
United KingdomSite Not Available
GSK Investigational Site
Ledbury, HR8 2DX
United KingdomSite Not Available
GSK Investigational Site
Birmingham, Alabama 35209
United StatesSite Not Available
GSK Investigational Site
Mesa, Arizona 85210
United StatesSite Not Available
GSK Investigational Site
Phoenix, Arizona 85050
United StatesSite Not Available
GSK Investigational Site
Sun City, Arizona 85351
United StatesSite Not Available
GSK Investigational Site
Anaheim, California 92801
United StatesSite Not Available
GSK Investigational Site
Burlingame, California 94010
United StatesSite Not Available
GSK Investigational Site
Long Beach, California 90806
United StatesSite Not Available
GSK Investigational Site
Newport Beach, California 92660
United StatesSite Not Available
GSK Investigational Site
Pasadena, California 91106
United StatesSite Not Available
GSK Investigational Site
Redondo Beach, California 90277
United StatesSite Not Available
GSK Investigational Site
Santa Monica, California 90404
United StatesSite Not Available
GSK Investigational Site
Stanford, California 94305-5548
United StatesSite Not Available
GSK Investigational Site
Winnetka, California 91306
United StatesSite Not Available
GSK Investigational Site
Boca Raton, Florida 33486
United StatesSite Not Available
GSK Investigational Site
Coeur D'Alene, Idaho 83814
United StatesSite Not Available
GSK Investigational Site
Springfield, Massachusetts 01104
United StatesSite Not Available
GSK Investigational Site
West Yarmouth, Massachusetts 02673
United StatesSite Not Available
GSK Investigational Site
Worcester, Massachusetts 01655
United StatesSite Not Available
GSK Investigational Site
Kalamazoo, Michigan 49048
United StatesSite Not Available
GSK Investigational Site
St. Paul, Minnesota 55101
United StatesSite Not Available
GSK Investigational Site
St. Louis, Missouri 63128
United StatesSite Not Available
GSK Investigational Site
Las Vegas, Nevada 89119
United StatesSite Not Available
GSK Investigational Site
Albany, New York 12205
United StatesSite Not Available
GSK Investigational Site
Tabor City, North Carolina 28463
United StatesSite Not Available
GSK Investigational Site
Fargo, North Dakota 58104
United StatesSite Not Available
GSK Investigational Site
Oklahoma City, Oklahoma 73104
United StatesSite Not Available
GSK Investigational Site
Warwick, Rhode Island 02886
United StatesSite Not Available
GSK Investigational Site
Burlington, Vermont 05401
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.